Introduction: Surgery is offered to patients with Graves' disease (GD) refractory to medical or radio-iodine therapy. Total thyroidectomy (TT) has been shown to lower recurrence rates of hyperthyroidism but subtotal thyroidectomy (ST) is thought to be associated with lower risk of postoperative complications. The aim of this study was to compare the postoperative outcomes of TT vs ST in the Singaporean population and identify risk factors that might predispose to treatment failure after ST.
INTRODUCTION
Graves' disease is the commonest cause of hyperthyroi dism. It is an autoimmune disorder characterized by an enlarged goiter, hyperthyroidism, and ophthalmopathy. 1 Untreated GD in the long term predisposes one to blind ness, cardiovascular comorbidities, and osteopenia and may carry significant morbidity and mortality. Treatment options for GD include antithyroid medications, radio iodine, or surgery. Indications for surgery in patients with GD include failure of medical management to antithyroid medications or radioiodine therapy, younger patients with high risk of recurrence following medical manage ment, large goiter with compressive symptoms, nodular thyroid where malignancy may coexist, severe Graves' ophthalmopathy, and patients' preference. 2 There has been much controversy about the surgical management of GD. Surgical options for GD include bilat eral ST, unilateral hemithyroidectomy with contralateral ST 35 and TT. 68 Recent guidelines have proposed TT as the procedure of choice for the surgical management of GD, 9 but other studies 10, 11 have argued that ST, especially when performed with a remnant thyroid of less than 3 gm, 12 may be associated with a low risk of recurrent hyperthyroidism. The ST is associated with lesser risk of hypoparathyroidism 13, 14 and possibly recurrent laryn geal nerve palsy. A Cochrane review found TT to be more effective in preventing recurrent hyperthyroidism compared with ST with greater risk of permanent hypoparathyroidism and no effect on recurrent laryngeal nerve palsy or regression of Graves' ophthalmopathy. 15 There is a paucity of literature reporting the reasons leading to relapse of hyperthyroidism after surgical therapy for GD. Kuma et al 16 reported that circulating levels of thyroid hormones, thyroidstimulating anti body, and thyroidstimulating hormone (TSH)binding immunoglobulin (TBII) did not predict for thyroid status postST. Sugino et al 17 reported that larger thyroid remnant size, antimicrosomal hemagglutination anti body and TBII predicted the need for TSH suppression within a year after ST. The purpose of the study was to report our experience of thyroidectomy for GD in a Southeast Asian popula tion as such data have not been previously reported in the literature; Further to that, we also aimed to elucidate the factors that predict treatment failure after ST in our population.
MATERIALS AND METHODS

Study Design
We utilized a historical cohort of consecutive patients undergoing thyroidectomy for GD in a tertiary university hospital. Data and outcomes were prospectively recorded in a paper or electronic database and examined retro spectively for the purpose of this study. Patients who underwent thyroid surgery for GD before 2006 received ST; those who underwent surgery after the year 2009 received TT. Patients who were operated on in the inter vening years received either procedure.
Setting/Participants
Consecutive patients undergoing either ST or TT for GD in a specialist endocrine surgery unit between January 1991 and December 2015 formed the study population. Patients younger than 18 years of age and those with missing followup data were excluded from the study. All patients who were scheduled for surgery presented either to the endocrine surgery service directly or were referrals from endocrinology or primary care clinics. Patients were counseled for surgery when they had large goiters with obstructive symptoms, hyperthyroid symptoms refrac tory to antithyroid, and/or radioiodine therapy, Graves' ophthalmopathy, allergies to antithyroid medication, or when there was suspicion of a concomitant malignant thyroid nodule.
Patient characteristics recorded included patient gender, ethnicity, preoperative laboratory results with TSH, free thyroxine, antithyroid peroxidase, antithy roglobulin, TSH receptor antibody, and preoperative thyroid volume as estimated by ultrasonography. The time of diagnosis until surgery, type of surgery per formed, duration of surgery, and volume of remnant thyroid when ST was performed were also recorded.
Surgical Technique
All patients underwent surgery under general anesthesia without cervical block.
For TT, subplatysmal flaps were raised following a transverse skin crease incision two finger breaths above the sternal notch. The cervical linea alba was then divided to gain access to the thyroid gland; strap muscles are not routinely divided. The dissection was then carried out anterolaterally toward the carotid sheath where the middle thyroid vein was ligated between ties. Subse quently, the superior pole was identified and the superior pedicle was divided between either ties or an energy device. The parathyroid glands and recurrent laryngeal nerve are routinely identified in the procedure. Dissection was then carried out in the cricothyroid space, taking care to preserve the contralateral recurrent laryngeal nerve and parathyroid glands. For TT, all visible thyroid tissues were excised. All other patients underwent bilateral ST in which 2 to 4 gm of normal thyroid tissue was left behind in the thyroid bed on each side. No patients underwent hemithyroidectomy or Dunhill procedure in this surgical series. Neuromonitoring was not used before the year 2011. All cases of thyroidectomy were performed with neuromonitoring since the year 2012 after change in the unit's thyroidectomy protocol.
Study Outcomes
Given that the current literature supports TT as the procedure of choice in GD patients undergoing surgical therapy, the primary outcomes examined for this study were the mean length of stay, incidence of hypocalcemia (temporary and permanent), hoarseness, and recurrent laryngeal nerve injury (temporary and permanent), and relapse of hyperthyroidism postsurgery. As there was no consensus in the current literature what con stitutes early or late complications, we took arbitrarily complications persisting more than 6 months to be permanent and those that resolved within 6 months as temporary complications. Patients were considered hypocalcemic when corrected serum calcium was less than 2.1 mmol/L or when they experienced symptoms suggestive of hypocalcemia. Treatment failure or relapse was considered to have occurred if patients were persis tently biochemically hyperthyroid or if they continued to exhibit clinical symptoms of hyperthyroidism after thyroidectomy. We do not routinely perform radioiodine scans after surgery.
We also wanted to study whether any factor might predict treatment failure after ST. The secondary outcome was to examine if preoperative thyroid volumes, remnant gland volumes, preoperative thyroid function tests, and antibodies levels predicted treatment failure in the sub group of patients who underwent ST.
Statistics
All categorical variables were compared using chi square tests with a pvalue of less than 0.05 considered wjoes statistically significant. The means of continuous vari ables, such as length of stay and laboratory results were compared using twotailed Student's t test. Statistical analysis was performed using Statistical Package for the Social Sciences version 21 (IBM SPSS Statistics for Macintosh, version 21.0).
RESULTS
Demographics
A total of 130 patients underwent thyroid surgery in the 25year period between January 1991 and December 2015. Of these, 13 patients were excluded due to missing followup data (Flow Chart 1). Patient demographics, as stratified according to whether they underwent ST or TT, is displayed in Table 1; 75 patients underwent bilateral ST before year 2006 and 27 patients who underwent surgery after the year 2009 received TT. In the intervening years, 11 out of 15 patients diagnosed with GD received TT.
Thyroid Status Postsurgery
Three patients had persistent hyperthyroidism postST. Overall, 4.3% (n = 5) patients were hyperthyroid and 71.8% (n = 84) of patients were hypothyroid at 6month follow up. On longterm followup, 16 
Postoperative Hypocalcemia
Among the patients, 55.6% (n = 65) developed hypo calcemia postthyroid surgery. Among these patients, hypocalcemia was temporary in 48 patients (41.0%) and resolved within 6 months. The rest of the 17 patients had permanent hypocalcemia and required regular calcium and vitamin D supplementation. Undergoing TT was associated with higher odds of developing hypocalce mia postoperatively overall (OR 1.96; 95% CI 1.08-3.57), but did not independently predict for both temporary (p = 0.229) and permanent hypocalcemia (p = 0.174).
Postoperative Hoarseness and Recurrent Laryngeal Nerve Injury
No intraoperative identification of recurrent laryngeal nerve injury was identified during this case series. The incidence of postoperative hoarseness was negligible in both ST and TT groups; 2.5% (n = 2) and 3.3% (n = 1) of patients postTT experienced hoarseness; 2 out of the 3 cases were performed without neuromonitoring. All three cases of postoperative hoarseness were transient and the patients recovered without active intervention.
Length of Hospitalization
Patients had slightly shorter hospitalization postST compared with patients who underwent TT (3.58 ± 1.12 vs 3.84 ± 3.404 days), but this did not reach statistical significance (p = 0.541). Table 2 demonstrates the preoperative values of thyroid function tests and antithyroid antibodies performed prior to patients undergoing ST. There was no significant differ ence between the preoperative levels of TSH, thyroxine, TSH receptor antibody, thyroid peroxidase, and antithy roglobulin between patients who experienced treatment failure compared with those who did not. Significantly, the mean thyroid volumes estimated by ultrasonography preoperatively were higher in patients who experienced relapse of hyperthyroidism (p = 0.024).
Factors predicting Failure of Therapy in Patients undergoing ST
DISCUSSION
Key Results
In our surgical series, patients with GD who underwent ST were almost twice as likely to experience recurrent hyperthyroidism compared with those who underwent TT. Significantly, patients who received TT had a higher risk of hypoparathyroidism although this did not trans late into longer hospitalization stay that was statistically significant. We also demonstrated that patients with a large goiter were more likely to relapse after ST; preopera tive thyroid function and thyroid antibody levels did not seem to exert any effect on treatment failure. In our case series, we observed a change in the trend from ST to TT for GD between the years 2007 and 2009. This may have been secondary to the emerging literature in the early 2000s regarding the superiority of TT with regard to lesser risk of relapse of hyperthyroidism after TT. We observed that patients who underwent ST had significantly larger thyroid volumes compared with those who underwent TT. Although this trend may partially explain why patients who underwent ST had higher recurrent hyperthyroidism rates in our series, we feel that this may have been due to a greater acceptance by patients and lower threshold for referral for surgery in GD in the more recent years.
Three patients in the ST subgroup had persistent hyperthyroidism postST. In Lepner et al 12 study, none of the patients after ST had recurrence of hyperthyroidism when followed up for a mean of 52 months. Annerbo et al 18 described reduction of GD relapse from 20 to 3.3% after the surgical method was changed from ST to TT. The authors cite that in spite of TT, recurrence of hyper thyroidism occurred due to remnant tissue high up at the hyoid bone. Given the risk of remnant thyroid left behind at the hyoid bone area coupled with 2 to 4 gm of thyroid left behind on both sides, the excessive amount of remnant thyroid gland may have contributed to the immediate treatment failure observed in the above three patients. In the subgroup of patients who underwent ST, we found that preoperative thyroid gland volume was a significant predictor for treatment failure even though remnant gland volume, preoperative thyroid status, and antibody levels were not. We observed that the amount of remnant gland between the groups of patients who had treatment failure did not differ significantly from those with no relapse. This supports our hypothesis that remnant thyroid tissue may have been left behind in areas of the neck that were not routinely explored, e.g., in the area of the hyoid bone. Similar to the reported literature, patients who under went TT in our series had significantly more hypocalce mia with no difference in rates of recurrent laryngeal nerve injury. Despite this, both patient groups had com parable length of stay postsurgery. This seems to suggest that even though patients were more likely to experience hypocalcemia postTT, the severity of hypocalcemia was not significantly more severe than those who underwent ST, as this would have necessitated intravenous calcium replacement which would have translated into longer hospitalization stay postoperatively.
Interestingly, we observed that over longterm follow up, a large proportion (60%) of our patients who received ST became hypothyroid and required thyroxine replace ment. This would undermine the purpose of performing ST, as one of the reported benefits of the procedure is the hope to maintain a euthyroid state without TSH sup pression therapy or thyroxine replacement long term. A previous study demonstrated that hypothyroidism after ST occurred in a bimodal pattern 19 and the mechanism of action is unclear 19 even though it may be associated with longer preoperative antithyroid drug treatment and sup pression of TSH. 20 Possible theories of hypothyroidism after bilateral ST include insufficient remnant thyroid left behind after surgery. In cases where patients experienced late onset hypothyroidism, this is likely to be the natural disease progression of GD where the remnant thyroid gland eventually "burns out", rendering the patient hypothyroid.
LIMITATIONS
The main limitation of our study lies in it being a retrospective review, even though data were collected prospectively. Given that the patient population spanned over a period of 25 years, there were missing data (espe cially laboratory investigations) that dated to the pre electronic era and such data could not be easily retrieved. Furthermore, laboratory reference ranges may have wjoes changed over a period of 25 years and our study was not able to adjust for these changes. We observed that patients receiving TT had a greater incidence of hypocalcemia, but TT predicted neither temporary nor permanent hypocalcemia. We believe that this may have been because our study was inadequately powered to show such a difference and a larger sample size would have demonstrated the effect of TT on both temporary and permanent hypoparathyroidism.
CONCLUSION
Our study findings are in agreement with what is already reported in the current literature, and current existing guidelines are also likely to be applicable in the Singaporean or Southeast Asian population. With our findings demonstrating lesser relapse of hyperthyroid ism and similar safety profiles of TT in tandem with a high proportion of patients eventually needing thyroxine replacement after ST, we believe that TT should be the surgical procedure of choice for patients with GD. We find little reason to continue to offer ST as an alternative.
